[1] 徐子琴, 张雪良. 我国重症医学科医院感染暴发的流行特征和应对策略[J]. 疾病监测, 2020, 35(10): 953-956. [2] 李曙光, 廖康, 苏丹虹, 等. 2018年中国11所教学医院院内感染常见病原菌分布和耐药性[J]. 中华医学杂志, 2020, 100(47): 3775-3783. [3] 安春荣, 任建伟, 朱光发, 等. 碳青霉烯类耐药鲍曼不动杆菌感染的临床特征与耐药性分析[J]. 心肺血管病杂志, 2024, 43(1): 35-40. [4] Kurihara MNL, Sales RO, Silva KED, et al.Multidrug-resistant Acinetobacter baumannii outbreaks: A global problem in healthcare settings[J]. Rev Soc Bras Med Trop, 2020, 6(53): e20200248. [5] Chang HC, Wei YF, Dijkshoorn L, et al.Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region[J]. J Clin Microbiol, 2005, 43(4): 1632-1639. [6] Woodford N, Ellington MJ, Coelho JM, et al.Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp[J]. Int J Antimicrob Agents, 2006, 27(4): 351-353. [7] Ellington MJ, Kistler J, Livermore DM, et al.Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases[J]. J Antimicrob Chemother, 2007, 59(2): 321-322. [8] Doi Y, Arakawa Y.16S ribosomal RNA methylation: Emerging resistance mechanism against aminoglycosides[J]. Clin Infect Dis, 2007, 45(1): 88-94. [9] Robicsek A, Strahilevitz J, Sahm DF, et al.qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States[J]. Antimicrob Agents Chemother, 2006, 50(8): 2872-2874. [10] Vila J, Ruiz J, Goñi P, et al.Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii[J]. Antimicrob Agents Chemother, 1995, 39(5): 1201-1203. [11] Vila J, Ruiz J, Goñi P, et al.Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii[J]. J Antimicrob Chemother, 1997, 39(6): 757-762. [12] Bartual SG, Seifert H, Hippler C, et al.Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii[J]. J Clin Microbiol, 2005, 43(9): 4382-4390. [13] Seifert H, Dolzani L, Bressan R, et al.Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii[J]. J Clin Microbiol, 2005, 43(9): 4328-4335. [14] 刘思娣, 陈丽华, 付陈超, 等. 湖南省细菌耐药监测网2012—2021年鲍曼不动杆菌耐药性监测报告[J]. 中国感染控制杂志, 2023, 22(12): 1460-1467. [15] 胡付品, 郭燕, 朱德妹, 等. 2019年CHINET三级医院细菌耐药监测[J]. 中国感染与化疗杂志, 2020, 20(3): 233-243. [16] Attia NM, Elbaradei A.Fluoroquinolone resistance conferred by gyrA, parC mutations, and AbaQ efflux pump among Acinetobacter baumannii clinical isolates causing ventilator-associated pneumonia[J]. Acta Microbiol Immunol Hung, 2019, 67(4): 234-238. [17] Zhou Y, Wu X, Zhang X, et al.Genetic Characterization of ST195 and ST365 carbapenem-resistant Acinetobacter baumannii harboring blaOXA-23 in Guangzhou, China[J]. Microb Drug Resist, 2015, 21(4): 386-390. [18] Qu J, Du Y, Yu R, et al.The first outbreak caused by Acinetobacter baumannii ST208 and ST195 in China[J]. Biomed Res Int, 2016, 2016: 9254907. [19] Leung EC, Leung PH, Lai RW.Emergence of carbapenem-resistant Acinetobacter baumannii ST195 harboring blaOXA-23 isolated from bacteremia in Hong Kong[J]. Microb Drug Resist, 2019, 25(8): 1199-1203. [20] Zhou K, Tang X, Wang L, et al.An emerging clone (st457) of acinetobacter baumannii clonal complex 92 with enhanced virulence and increasing endemicity in South China[J]. Clin Infect Dis, 2018, 67(suppl 2): S179-S188. |